[FATE] YoY Quarter Result on 30-Sep-2016 [#Q3]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
07-Nov-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- -3.91%
YoY- -26.88%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Revenue 2,429 1,026 1,026 1,026 1,026 0 209 50.47%
PBT -26,609 -16,782 -10,684 -8,737 -6,886 -6,603 -6,073 27.90%
Tax 910 339 378 37 4 187 0 -
NP -26,609 -16,782 -10,684 -8,737 -6,886 -6,603 -6,073 27.90%
Tax Rate - - - - - - - -
Total Cost 29,038 17,808 11,710 9,763 7,912 6,603 6,282 29.05%
Ratio Analysis
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
NP Margin -1,095.47 -1,635.67 -1,041.33 -851.56 -671.15 0.00 -2,905.74 -14.99%
Per Share
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
EPS -0.40 -0.31 -0.26 -0.27 -0.24 -0.32 -0.32 3.78%
EPS Diluted -0.40 -0.31 -0.26 -0.27 -0.24 -0.32 -0.32 3.78%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.